- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00445926
Evaluation of the H1-coil Deep TMS in the Treatment of Negative Symptoms and Cognitive Deficit in Schizophrenia
May 5, 2010 updated by: Shalvata Mental Health Center
Deep TMS With the H Coils as a Novel Strategy for the Treatment of Negative Symptoms of Schizophrenia
The study evaluates the feasibility of using a 4 week stimulation protocol with the deep TMS H-coils for the treatment of negative symptoms and cognitive deficit in schizophrenia patients
Study Overview
Study Type
Interventional
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hod Hasharon, Israel
- Shalvata MHC
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- DSM IV Diagnosis of Schizophrenia
- PANNS Negative > 21
Exclusion Criteria:
- risk factors for convulsions
- PANNS positive > 24
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Eiran V Harel, MD, Shalvata MHC
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2006
Primary Completion (Actual)
May 1, 2009
Study Completion (Actual)
May 1, 2009
Study Registration Dates
First Submitted
March 8, 2007
First Submitted That Met QC Criteria
March 8, 2007
First Posted (Estimate)
March 9, 2007
Study Record Updates
Last Update Posted (Estimate)
May 6, 2010
Last Update Submitted That Met QC Criteria
May 5, 2010
Last Verified
May 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SH-40206
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Bradley LegaRecruiting
-
All India Institute of Medical Sciences, BhubaneswarRecruitingTreatment Resistant SchizophreniaIndia
-
King's College LondonSouth London and Maudsley NHS Foundation TrustRecruitingTreatment-resistant Schizophrenia | Healthy Controls | Treatment-responsive SchizophreniaUnited Kingdom
-
University of Sao PauloUnknownRefractory Schizophrenia | Super Refractory SchizophreniaBrazil
-
Ohio State UniversityRecruitingTreatment-resistant SchizophreniaUnited States
-
University Hospital, BrestRecruitingSchizophrenia | Schizophrenia Prodromal | Schizophrenia, ChildhoodFrance
-
NYU Langone HealthNot yet recruitingTreatment-resistant SchizophreniaUnited States
-
Johns Hopkins UniversityNational Institute of Mental Health (NIMH)RecruitingTreatment-resistant SchizophreniaUnited States
Clinical Trials on deep TMS H-coil
-
BrainswayUnknownMild Cognitive ImpairmentIsrael
-
BrainswayCompletedMajor Depressive DisorderUnited States, Canada, Germany, Israel, France
-
Shalvata Mental Health CenterUnknownMarijuana AbuseIsrael
-
BrainswayCompletedMajor Depressive Disorder, Recurrent, Unspecified | Major Depressive Disorder, Single Episode, UnspecifiedUnited States, Canada, Germany, Israel
-
Shalvata Mental Health CenterUnknown
-
BeerYaakov Mental Health CenterWeizmann Institute of ScienceUnknown
-
Shalvata Mental Health CenterBrainswayUnknownBipolar DepressionIsrael
-
Soroka University Medical CenterBen-Gurion University of the NegevUnknown
-
St. Joseph's Healthcare HamiltonPeter Boris Centre for Addictions Research (PBCAR)Recruiting
-
Centre for Addiction and Mental HealthCanadian Institutes of Health Research (CIHR); BrainswayCompleted